US Stock MarketDetailed Quotes
GNFT Genfit
- 5.610
- +0.230+4.28%
Close Sep 26 16:00 ET
279.98MMarket Cap13.62P/E (TTM)
5.700High5.340Low9.55KVolume5.700Open5.380Pre Close53.14KTurnover0.02%Turnover RatioLossP/E (Static)49.91MShares6.05052wk High2.58P/B235.59MFloat Cap2.89452wk Low--Dividend TTM41.99MShs Float26.250Historical High--Div YieldTTM6.69%Amplitude2.894Historical Low5.564Avg Price1Lot Size
Genfit Stock Forum
Sign in to post a comment
$Genfit (GNFT.US)$ Ipsen, Genfit Medicine Is Cleared by FDA for Rare Liver Disorder
The drug will be called Iqirvo, Ipsen said in a statement Monday. (Bloomberg) -- Ipsen SA and partner Genfit SA won US regulators’ clearance for the first new treatment option in eight years for patients with a rare liver disease.
The US Food and Drug Administration approved the medicine, elafibranor, for adults with primary biliary cholangitis, an autoimmune disease in whi...
The drug will be called Iqirvo, Ipsen said in a statement Monday. (Bloomberg) -- Ipsen SA and partner Genfit SA won US regulators’ clearance for the first new treatment option in eight years for patients with a rare liver disease.
The US Food and Drug Administration approved the medicine, elafibranor, for adults with primary biliary cholangitis, an autoimmune disease in whi...
3
🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline (GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline (GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...
10
1
$Genfit (GNFT.US)$
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - 10 June 2024 - 12 mins read
Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver disease called primary biliary cholangitis
Approval based on positive Phase III ELATIVE trial data Primary biliary cholangitis impacts approximately 100,000 people in the US and is g...
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - 10 June 2024 - 12 mins read
Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver disease called primary biliary cholangitis
Approval based on positive Phase III ELATIVE trial data Primary biliary cholangitis impacts approximately 100,000 people in the US and is g...
1
$Genfit (GNFT.US)$
GENFIT Says Iqirvo Is First-ever Drug Developed In-house By Company To Achieve FDA Approval; Expects To Receive Milestone Payments From Ipsen
GENFIT Says Iqirvo Is First-ever Drug Developed In-house By Company To Achieve FDA Approval; Expects To Receive Milestone Payments From Ipsen
1
» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Eli Lilly and Co (LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron (GERN.US)$ : Imetelstat
$Merck & Co (MRK.US)$ : V116
$Amgen (AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Merck & Co (MRK.US)$ : KEYTRUDA ...
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Eli Lilly and Co (LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron (GERN.US)$ : Imetelstat
$Merck & Co (MRK.US)$ : V116
$Amgen (AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Merck & Co (MRK.US)$ : KEYTRUDA ...
16
In May 2024, my investments took a hit, with a loss at around 1.88%. Remember, investing comes with highs and lows, so it's important to stick to my long-term plan, especially when the market is unpredictable.
June’s investment tactic
I’m thinking about putting more money into biotech stocks through dollar-cost averaging. Biotech stocks can be risky due to factors like drug trials and regulations. I will continue to keep an eye on earnings reports for biotech companies, as they ...
June’s investment tactic
I’m thinking about putting more money into biotech stocks through dollar-cost averaging. Biotech stocks can be risky due to factors like drug trials and regulations. I will continue to keep an eye on earnings reports for biotech companies, as they ...
5
See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb (BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna (MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals (CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro...
$Bristol-Myers Squibb (BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna (MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals (CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro...
8
1
$Genfit (GNFT.US)$ Accept my paper Trade I'm on Pending??
1
$Brainstorm Cell Therapeutics (BCLI.US)$ - Stock forming a nice pattern on the daily. If holds above $4 we can see a bigger run.
$BridgeBio Pharma (BBIO.US)$ - stock bouncing after getting beaten down after the company's phase 3 trial to treat symptomatic transthyretin amyloid cardiomyopathy did not achieve its primary endpoint.
$Takung Art (TKAT.US)$ - stock moving higher after getting some volume. Looking for $5 plus move.
$Lucid Group (LCID.US)$ - stock in consolidation mode. Unable to break $40....
$BridgeBio Pharma (BBIO.US)$ - stock bouncing after getting beaten down after the company's phase 3 trial to treat symptomatic transthyretin amyloid cardiomyopathy did not achieve its primary endpoint.
$Takung Art (TKAT.US)$ - stock moving higher after getting some volume. Looking for $5 plus move.
$Lucid Group (LCID.US)$ - stock in consolidation mode. Unable to break $40....
3
$Lucid Group (LCID.US)$ - stock in consolidation mode. Unable to break $40. On watch break out above it.
$Pfizer (PFE.US)$ - Stock in consolidation mode. Needs to hold above $78. On watch for break out higher.
$Insignia Systems (ISIG.US)$ - Watching Insignia Systems; Traders Circulate Reddit Post On Potential Short Squeeze. On watch for another run if holds above $18
$Genfit (GNFT.US)$ - Stock in an uptrend and holding above $5 nicely. On watch for more higher.
$Cumberland Pharmaceuticals (CPIX.US)$ - Stock st...
$Pfizer (PFE.US)$ - Stock in consolidation mode. Needs to hold above $78. On watch for break out higher.
$Insignia Systems (ISIG.US)$ - Watching Insignia Systems; Traders Circulate Reddit Post On Potential Short Squeeze. On watch for another run if holds above $18
$Genfit (GNFT.US)$ - Stock in an uptrend and holding above $5 nicely. On watch for more higher.
$Cumberland Pharmaceuticals (CPIX.US)$ - Stock st...
3
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
QM137over1 : Friend when will the Fed cut interest rates![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP QM137over1 : I have no clue! I have a feeling that the FED on BIDENS directions will try to do something before the election to try and show he is now doing something? But it will backfire because they are not following the numbers! IMO anyways. Hehehe
QM137over1 Trytosaveabit OP :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Looks like you don't really like Biden. Trump has had quite a bit of trouble lately![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Do you like Trump?![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")